Research findings from full-length T4 studies cannot be assumed to apply directly to the fragment
Looking Ahead As research progresses, GLP-1 therapies are being explored in combination with other hormones, such as GIP (glucose-dependent insulinotropic polypeptide), in drugs like tirzepatide
GHK-Cu is administered via subcutaneous injection: under the skin, into the fat layer
York B, Reineke EL, Sagen JV, Nikolai BC, Zhou S, Louet JF, Chopra AR, Chen X, Reed G, Noebels J, Adesina AM, Yu H, Wong LJ, Tsimelzon A, Hilsenbeck S, Stevens RD, Wenner BR, Ilkayeva O, Xu J, Newgard CB, OMalley BW
The percentage of patients who had a glycated hemoglobin level of 6.5% or less was 73.5% in the cagrilintide-semaglutide group and 15.9% in the placebo group
References et al